Teams
-
-
Jean-Paul Bonnefont
>> Reference center for rare diseases
CARAMMEL - Mitochondrial diseases in children and adults
Imagine's Offers
-
Neurodegeneration with brain iron accumulation (NBIA)Genotype Phenotype
-
Cohorts
Around 10 patients
-
TNGS / WES / WGS*
"Mitome" gene panel for mitochondrial diseases
*Targeted Next Generation Sequencing Gene Panel
-
Patient samples
Fibroblasts
Targets-
Specific targets
CRAT, REPS1, etc.
Therapeutics-
Specific biomarkers
Please, contact us
-
Patents
Methods and pharmaceutical compositions for the treatment of neurodegeneration with brain iron accumulation (WO2018115012)
Second patent (please, contact us)
-
Specific therapeutic approaches
Repurposing
Clinical trialsFriedreich AtaxiaGenotype Phenotype-
Cohorts
> 200 pediatric and adult patients
-
Patient samples
Fibroblasts
Targets-
Specific targets
FXN
Therapeutics-
Specific biomarkers
Please contact us (see patents)
-
Patents
Methods and pharmaceutical compositions for the treatment of neurodegeneration with brain iron accumulation (WO2018115012)
Second patent (please, contact us) -
Specific therapeutic approaches
Gene therapy
Repurposing
Clinical trials -
-
Mitochondrial DNA related disordersGenotype Phenotype
-
Cohorts
Patients with different mitochondrial diseases (please, contact us)
-
TNGS / WES / WGS*
"Mitome" gene panel for mitochondrial diseases
-
Patient samples
Fibroblasts
TargetsTherapeuticsClinical trials -
-
Respiratory chain subunits defectsGenotype Phenotype
-
Cohorts
> 400 pediatric and adult patients with different mitochondrial diseases (please, contact us)
-
TNGS / WES / WGS*
"Mitome" gene panel for mitochondrial diseases
-
Patient samples
Fibroblasts
Targets-
Protocols/Technics
Measurement of mitochondrial respiration (Oroboros technology)
Analysis of respiratory chain assembly (BN-PAGE)
TherapeuticsClinical trials -
-
mtDNA maintenance defectsGenotype Phenotype
-
Cohorts
> 60 pediatric and adult patients with different mitochondrial diseases
-
TNGS / WES / WGS*
"Mitome" gene panel for mitochondrial diseases
-
Patient samples
Fibroblasts
TargetsTherapeutics-
Specific therapeutic approaches
Gene therapy approaches to treat mitochondrial diseases caused by defects in mitochondrial gene expression
Clinical trials -
-
Mitochondrial translation defectsGenotype Phenotype
-
Cohorts
> 70 pediatric and adult patients with different mitochondrial diseases
-
TNGS / WES / WGS*
"Mitome" gene panel for mitochondrial diseases
-
Patient samples
Fibroblasts
Targets-
In vivo models
Conditional KO mouse model - confidential, please contact us
-
Protocols/Technics
Synthesis of mitochondrially encoded proteins
-
Specific targets
Confidential, please contact us
TherapeuticsClinical trials -
Contacts
-
Thibaut PERCHET
Business development manager
- thibaut.perchet@institutimagine.org
- +33 1 42 75 42 55